ArticleInternational dental journal2026
Fusobacterium nucleatum-Derived Outer Membrane Vesicles Disrupt Epithelial Barrier in Oral Lichen Planus via JNK/c-JUN Mediated Claudin-4 Downregulation.
Article in International dental journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
INTRODUCTION AND
aimsOral lichen planus (OLP) is a chronic inflammatory disease of unknown etiology. Recent studies have implicated microbial dysbiosis in its pathogenesis. Our previous research revealed an increased abundance of Fusobacterium nucleatum (F.nucleatum) in OLP tissues, suggesting its potential involvement.
methodsWe utilized single-cell RNA sequencing, spatial transcriptomics, and immunohistochemistry to analyse Claudin-4 expression and its spatial distribution in OLP lesions. In vitro, HaCaT keratinocytes exposed to outer membrane vesicles (OMVs) derived from F.nucleatum (F.n-OMVs) were evaluated for epithelial barrier function via transepithelial electrical resistance (TEER) and fluorescein isothiocyanate-dextran (FD4) permeability assays. Claudin-4 expression and JNK/c-JUN pathway activation were evaluated by qPCR, Western blotting, and RNA sequencing. The JNK inhibitor SP600125 was used to explore pathway involvement.
resultsClaudin-4 expression was significantly decreased and exhibited disrupted spatial organization in OLP lesions. F.n-OMVs compromised HaCaT epithelial barrier function, downregulated Claudin-4 expression, and altered its localization. Western blotting demonstrated activation of the JNK/c-JUN signaling pathway. Inhibition of JNK with SP600125 restored Claudin-4 expression and barrier function.
conclusionOur study demonstrates that F.n-OMVs induce epithelial barrier dysfunction in OLP by activating the JNK/c-JUN pathway to downregulate Claudin-4, highlighting a novel microbial mechanism contributing to OLP pathogenesis. CLINICAL RELEVANCE: These findings identify F.n-OMVs as microbial drivers of epithelial barrier disruption in OLP, suggesting that targeting OMVs or the JNK/c-JUN/Claudin-4 axis may offer new diagnostic and therapeutic strategies for OLP management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.